DIET, HDL, AND REVERSE CHOLESTEROL TRANSPORT

饮食、高密度脂蛋白和胆固醇反向运输

• 批准号: 6638268
• 负责人: JAY D. HORTON
• 金额: $ 26.45万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-04-01 至 2004-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6638268
• 关键词: blood lipoprotein metabolism; blood lipoprotein transport; cholanate compound; cholesterol; cholesterol esters; dietary constituent; dietary lipid; enzyme activity; excretion; gene expression; genetically modified animals; hamsters; high density lipoproteins; laboratory mouse; lipid transport; liver metabolism; low density lipoprotein; nutrient interaction; nutrition related tag; phosphatidylcholine sterol acyltransferase; receptor expression; steroid biosynthesis; transport proteins

Cholesterol that is acquired by most extrahepatic tissues must be returned to the liver for excretion in a process that has been termed reverse cholesterol transport. The concept of reverse cholesterol transport is based mainly on biochemical studies of individual enzymes thought to be involved in reverse cholesterol transport and studies of cholesterol efflux from cultured cells. More recently, proteins thought to be involved in reverse cholesterol transport have been knocked out or overexpressed in mice. However, there is no direct evidence that reverse cholesterol transport has been altered in any of these models. To date, an unambiguous demonstration of the reverse cholesterol transport pathway has not been obtained in whole animals. In preliminary studies we demonstrated the net (mass) movement of cholesterol from individual extrahepatic tissues into reconstituted nascent prebeta-migrating HDL in vivo and showed that this initial step in reverse cholesterol transport can be greatly accelerated. Here we propose to characterize the major steps in reverse cholesterol transport in vivo and to demonstrate sequentially that each step in the reverse cholesterol transport pathway can be accelerated resulting in the net (mass) movement of cholesterol from extrahepatic tissues to the liver for excretion into bile. Finally, we will demonstrate that cholesterol flux through the entire reverse cholesterol transport pathway can be accelerated in vivo resulting in the net movement of cholesterol from individual extrahepatic tissues into feces. These goals are now feasible because of methodological advances that allow us to quantify, for the first time, the major pathways of sterol flux in all tissues of the body in vivo. The specific aims are: (1) to characterize the initial step in the reverse cholesterol transport pathway in vivo in terms of the effect of enhanced cholesterol efflux on pathways of cholesterol acquisition by extrahepatic tissues, the effect of acceptor particle composition on cholesterol efflux and the effect of diet on cholesterol efflux, (2) to characterize the effects of overexpressing lecithin cholesterol acyl transferase (LCAT) on reverse cholesterol transport in vivo, (3) To determine the metabolic consequences of increasing the flux of HDL cholesteryl ester or LDL cholesterol to the liver and (4) to demonstrate that cholesterol flux through the entire reverse cholesterol transport pathway can be accelerated in vivo resulting in the net movement of cholesterol from extrahepatic tissues into feces both in animals that lack and in animals that possess cholesteryl ester transfer protein (CETP).

大多数肝外组织获得的胆固醇必须返回肝脏进行排泄，这一过程被称为胆固醇逆向转运。 胆固醇反向转运的概念主要基于对被认为参与胆固醇反向转运的单个酶的生化研究以及对培养细胞中胆固醇流出的研究。最近，被认为参与胆固醇反向转运的蛋白质已在小鼠体内被敲除或过度表达。 然而，没有直接证据表明逆转胆固醇转运在这些模型中发生了改变。迄今为止，尚未在整个动物中获得胆固醇反向转运途径的明确证明。在初步研究中，我们证明了胆固醇从单个肝外组织到体内重构的新生前β-迁移HDL的净（质量）运动，并表明反向胆固醇转运的这一初始步骤可以大大加速。 在这里，我们建议描述体内反向胆固醇转运的主要步骤，并依次证明反向胆固醇转运途径中的每个步骤都可以加速，导致胆固醇从肝外组织到肝脏的净（质量）运动，以排泄到胆汁中。 最后，我们将证明通过整个反向胆固醇转运途径的胆固醇通量可以在体内加速，导致胆固醇从单个肝外组织净移动到粪便中。这些目标现在是可行的，因为方法论的进步使我们首次能够量化体内所有组织中甾醇流动的主要途径。 具体目标是：（1）根据增强的胆固醇流出对肝外组织胆固醇获取途径的影响、受体颗粒组合物对胆固醇流出的影响以及饮食对胆固醇流出的影响来表征体内反向胆固醇转运途径的初始步骤，（2）表征过表达卵磷脂胆固醇酰基的影响 转移酶（LCAT）对体内反向胆固醇转运的影响，（3）确定增加HDL胆固醇酯或LDL胆固醇流向肝脏的代谢后果，以及（4）证明通过整个反向胆固醇转运途径的胆固醇通量可以在体内加速，导致胆固醇从肝外组织净移动到粪便中 无论是在缺乏胆固醇酯转移蛋白（CETP）的动物中还是在具有胆固醇酯转移蛋白（CETP）的动物中。